Artificial Intelligence In Ultrasound Imaging Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

AI in ultrasound imaging encompasses software and hardware solutions that use artificial intelligence to improve image quality, automate measurements, detect abnormalities, and assist operators during ultrasound examinations. The technology addresses longstanding challenges in ultrasound, including operator dependency, variable image quality, and the need for specialized training. Current market offerings range from cloud-based analytics platforms to embedded AI features in next-generation ultrasound systems.

• •Market valued at approximately $1.14 billion in 2025, with projections reaching $2.52 billion by 2035 at an 8.6% CAGR
• •Technology categories include machine learning, computer vision, deep learning, and natural language processing applied to ultrasound workflows
• •Primary applications span cardiac imaging, obstetric ultrasound, musculoskeletal assessment, point-of-care ultrasound, and tumor detection

The growing burden of chronic diseases such as cardiovascular conditions, cancer, and liver disease is increasing demand for accurate and accessible diagnostic imaging. Ultrasound's advantages, portability, real-time imaging, lack of ionizing radiation, and lower cost compared to MRI or CT, make it well-suited for expansion into point-of-care and screening applications, where AI can help compensate for limited operator expertise. Healthcare systems are also seeking AI tools to improve efficiency and reduce the time required for image acquisition and interpretation.

• •Shortage of trained sonographers in many regions creates demand for AI-assisted tools that enable less experienced operators to obtain diagnostic-quality images
• •Aging populations and rising prevalence of lifestyle-related diseases are increasing the volume of imaging procedures requiring ultrasound
• •Healthcare cost pressures and value-based care models incentivize adoption of technologies that reduce exam times and improve diagnostic consistency

The market is typically segmented by technology type, including machine learning, computer vision, deep learning, and natural language processing, as well as by application area such as cardiology, obstetrics and gynecology, radiology, urology, and point-of-care settings. North America currently represents the largest regional market, supported by advanced healthcare infrastructure, high technology adoption rates, and strong investment in medical AI research. Europe follows, while the Asia-Pacific region is expected to see the fastest growth due to expanding healthcare access, rising patient populations, and increasing government support for digital health initiatives.

• •By technology, deep learning and computer vision segments dominate due to their effectiveness in image analysis and pattern recognition
• •North America leads in market share, while Asia-Pacific emerges as the fastest-growing region driven by China, India, and Japan
• •Point-of-care ultrasound applications are among the fastest-expanding segments as handheld and portable devices become more widespread

What are the recent trends and outlook?

Future development is trending toward fully autonomous or semi-autonomous ultrasound procedures, where AI systems guide probe positioning, capture images, and provide preliminary interpretations without continuous specialist oversight. Cloud-based platforms are enabling remote image storage, analysis, and collaboration, potentially expanding access to quality ultrasound interpretation in underserved areas. Regulatory pathways for AI medical devices continue to mature, with increasing numbers of products receiving FDA 510(k) clearances and CE marks for specific clinical indications.

• •Fully automated screening applications, such as AI-guided carotid ultrasound and fetal anomaly detection, are progressing through clinical validation
• •Integration of AI with other imaging modalities and electronic health record data is expected to create more comprehensive diagnostic decision-support systems
• •Reimbursement pathway development and clinical evidence generation remain critical factors influencing broader adoption across healthcare systems